Compounds > 1-hexadecyl-2-acetyl-glycero-3-phosphocholine
Page last updated: 2024-09-02

1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Critical Illness

1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with Critical Illness in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Graham, RM; Leong, LL; Silvester, W; Stephens, CJ; Sturm, MJ; Taylor, RR1

Other Studies

1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Critical Illness

ArticleYear
Plasma degradation of platelet-activating factor in severely ill patients with clinical sepsis.
    Critical care medicine, 1994, Volume: 22, Issue:2

    Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Critical Illness; Half-Life; Humans; Infections; Lipids; Male; Middle Aged; Phospholipases A; Phospholipases A2; Platelet Activating Factor; Prospective Studies

1994